ArticleFrontiers in oncology2022

Identification of a novel RMST-ALK rearrangement in advanced lung adenocarcinoma and durable response to ceritinib: A case report.

Hui Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.